OCT 14, 2021 6:00 AM PDT

RSV Infections Can Modify Host Immune Gene Activity

WRITTEN BY: Carmen Leitch

Respiratory syncytial virus (RSV) infections are thought to be incredibly common; research has suggested that almost everyone is eventually infected. Usually, the virus only causes symptoms that resemble a mild cold but in some people, like young kids who haven't been infected before or older individuals with waning immunity, the virus can cause problematic lung infections that sometimes lead to death. New research has provided some insight into how the virus can cause a serious illness. This work, which was published in Cell Reports, has shown that one of the proteins produced by the viral genome, called NS1 (nonstructural protein 1), can modulate the activity of host cell immune genes and disrupt the immune response.

A TEM image of human respiratory syncytial virus (RSV) / Credit: Centers for Disease Control and Prevention/ E. L. Palmer

This research could help scientists develop new treatments for RSV infection, and may help investigators learn why the virus can increase asthma risk. Children that are infected with RSV are about 30 to 40 percent more likely to develop recurrent asthma or wheezing compared to the general population. Right now, there is no vaccine or treatment for RSV.

"RSV is a significant health burden. It leads to thousands of hospitalizations and a significant number of deaths in the U.S. every year," noted co-senior study author Daisy W. Leung, Ph.D., an associate professor of medicine and other departments at the Washington University School of Medicine in St. Louis. "NS1 is an important part of the reason RSV is capable of causing disease. Not only does the protein interfere with the immune response, it is also important for viral replication."

Previous work by Leung's team identified NS1 as one way RSV can evade the immune system. This latest research has revealed the mechanism behind that function. In this study, the scienitsts saw that the NS1 protein went to the nucleus of cells. Further work indicated that the protein was affecting the expression of immune genes; apparently, the NS1 protein is binding to other proteins that regulate host gene activity. The genes that were more significantly impacted by the viral protein were the ones that are normally activated when a virus infects a cell.

Now that researchers know that NS1 is moving to the nucleus to alter immune gene activity, they may be able to use that information to create a vaccine or therapy for RSV infection.

Sources: Washington University School of Medicine, Cell Reports

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 23, 2021
Cell & Molecular Biology
A New DNA Editor Hidden in a Microbial Jumping Gene
SEP 23, 2021
A New DNA Editor Hidden in a Microbial Jumping Gene
The technology for CRISPR originated in a bacterial immune defense system. Now, the team of one of the researchers who h ...
OCT 10, 2021
Genetics & Genomics
Who Were the Etruscans? A Genetic Study Provides Some Answers
OCT 10, 2021
Who Were the Etruscans? A Genetic Study Provides Some Answers
The Etruscans lived in what is now Italy from about 800 BCE to the first century CE. Their language is now gone...
OCT 26, 2021
Genetics & Genomics
In a First, Bach1 Protein Linked to Parkinson's, Revealing Potential Treatment
OCT 26, 2021
In a First, Bach1 Protein Linked to Parkinson's, Revealing Potential Treatment
One of the most common neurodegenerative disorders is Parkinson's disease, impacting an estimated 10 million people arou ...
NOV 04, 2021
Microbiology
Investigating the Gut Virome
NOV 04, 2021
Investigating the Gut Virome
The gut microbiome is a critical part of human health. Research has shown that many types of bacteria may reside there. ...
NOV 18, 2021
Health & Medicine
What is TurboKnockout® Gene Targeting Technology?
NOV 18, 2021
What is TurboKnockout® Gene Targeting Technology?
Cyagen's innovative TurboKnockout(R); technology is an advanced version of ES cell-mediated gene targeting, which has sh ...
NOV 23, 2021
Clinical & Molecular DX
Scientists Enter Uncharted Territory of the Cancer Genome, Emerge Victorious
NOV 23, 2021
Scientists Enter Uncharted Territory of the Cancer Genome, Emerge Victorious
Cancer is a genetic disease—it stems from specific changes in the DNA sequences of the cancer cell genome. Over th ...
Loading Comments...